|
Cohn, D H; Byers, P H (1991) Cysteine in the triple helical domain of the pro alpha 2(I) chain of type-I collagen in nonlethal forms of osteogenesis imperfecta. Hum Genet 87:167-72
|
|
Cohn, D H; Starman, B J; Blumberg, B et al. (1990) Recurrence of lethal osteogenesis imperfecta due to parental mosaicism for a dominant mutation in a human type I collagen gene (COL1A1). Am J Hum Genet 46:591-601
|
|
Byers, P H; Bonadio, J F; Cohn, D H et al. (1988) Osteogenesis imperfecta: the molecular basis of clinical heterogeneity. Ann N Y Acad Sci 543:117-28
|
|
Cohn, D H; Wenstrup, R J; Willing, M C et al. (1988) General strategies for isolating the genes encoding type I collagen and for characterizing mutations which produce osteogenesis imperfecta. Ann N Y Acad Sci 543:129-35
|
|
Cohn, D H; Apone, S; Eyre, D R et al. (1988) Substitution of cysteine for glycine within the carboxyl-terminal telopeptide of the alpha 1 chain of type I collagen produces mild osteogenesis imperfecta. J Biol Chem 263:14605-7
|
|
Byers, P H; Starman, B J; Cohn, D H et al. (1988) A novel mutation causes a perinatal lethal form of osteogenesis imperfecta. An insertion in one alpha 1(I) collagen allele (COL1A1). J Biol Chem 263:7855-61
|
|
Cohn, D H; Byers, P H (1988) Osteogenesis imperfecta and other inherited disorders of the structure and synthesis of type I collagen: models for the analysis of mutations that result in inherited chondrodysplasias. Pathol Immunopathol Res 7:132-8
|
